Stryeck, S., Gastrager, M., Degoricija, V., Trbušić, M., Potočnjak, I., Radulović, B. ... Frank, S. (2019). Serum concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are associated with increased 3-month mortality in acute heart failure patients. Scientific Reports, 9. (1). doi: 10.1038/s41598-019-42937-w
Stryeck, Sarah, et al. "Serum concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are associated with increased 3-month mortality in acute heart failure patients." Scientific Reports, vol. 9, no. 1, 2019. https://doi.org/10.1038/s41598-019-42937-w
Stryeck, Sarah, Michaela Gastrager, Vesna Degoricija, Matias Trbušić, Ines Potočnjak, Bojana Radulović, Gudrun Pregartner, Andrea Berghold, Tobias Madl and Saša Frank. "Serum concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are associated with increased 3-month mortality in acute heart failure patients." Scientific Reports 9, no. 1 (2019). https://doi.org/10.1038/s41598-019-42937-w
Stryeck, S., et al. (2019) 'Serum concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are associated with increased 3-month mortality in acute heart failure patients', Scientific Reports, 9(1). doi: 10.1038/s41598-019-42937-w
Stryeck S, Gastrager M, Degoricija V, Trbušić M, Potočnjak I, Radulović B, and sur.. Serum concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are associated with increased 3-month mortality in acute heart failure patients. Scientific Reports [Internet]. 2019 May 01 [cited 2024 October 13];9(1). doi: 10.1038/s41598-019-42937-w
S. Stryeck, et al., "Serum concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are associated with increased 3-month mortality in acute heart failure patients", Scientific Reports, vol. 9, no. 1, May 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:475691. [Accessed: 13 October 2024]